GT Biopharma Operating Cycle 2011-2026 | GTBP

Quarterly Operating Cycle GT Biopharma

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	551	246	-	-	51.1	385	87.5	-	168	-	3.24 K	-	137	73	-

All numbers in USD currency

Maximum	Minimum	Average
3.24 K	51.1	549

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Alnylam Pharmaceuticals ALNY	102	$ 333.39	-	$ 43.7 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Amphastar Pharmaceuticals AMPH	237	$ 21.68	-	$ 1.01 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Akebia Therapeutics AKBA	210	$ 1.55	-	$ 399 M	USA
Aquestive Therapeutics AQST	223	$ 4.24	-	$ 453 M	USA
Arcutis Biotherapeutics ARQT	291	$ 24.58	-	$ 3.13 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	129	$ 1.49	-	$ 397 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	321	$ 33.87	-	$ 2.25 B	USA
Clearside Biomedical CLSD	61.7	-	-	$ 25.3 M	USA